Pubblicazioni

Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease

2017 - GASTROENTEROLOGY

Hyams, Jeffrey S.; Dubinsky, Marla C.; Baldassano, Robert N.; Colletti, Richard B.; Cucchiara, Salvatore; Escher, Johanna; Faubion, William; Fell, John; Gold, Benjamin D.; Griffiths, Anne; Koletzko, Sibylle; Kugathasan, Subra; Markowitz, James; Ruemmele, Frank M.; Veereman, Gigi; Winter, Harland; Masel, Nicholas; Shin, Chu Ri; Tang, Kezhen L.; Thayu, Meena